持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/07/19 | 3,215 | 3,230 | 3,210 | 3,225 | +25 | +0.8% | 21,600 |
| 2023/07/18 | 3,190 | 3,215 | 3,190 | 3,200 | +15 | +0.5% | 15,300 |
| 2023/07/14 | 3,180 | 3,200 | 3,150 | 3,185 | +15 | +0.5% | 30,700 |
| 2023/07/13 | 3,165 | 3,190 | 3,150 | 3,170 | +5 | +0.2% | 27,700 |
| 2023/07/12 | 3,195 | 3,195 | 3,160 | 3,165 | ±0 | ±0% | 21,800 |
| 2023/07/11 | 3,200 | 3,210 | 3,165 | 3,165 | -35 | -1.1% | 45,500 |
| 2023/07/10 | 3,210 | 3,225 | 3,195 | 3,200 | -10 | -0.3% | 40,100 |
| 2023/07/07 | 3,215 | 3,245 | 3,200 | 3,210 | -30 | -0.9% | 38,700 |
| 2023/07/06 | 3,260 | 3,265 | 3,215 | 3,240 | -20 | -0.6% | 41,000 |
| 2023/07/05 | 3,250 | 3,265 | 3,235 | 3,260 | +5 | +0.2% | 35,100 |
| 2023/07/04 | 3,270 | 3,280 | 3,255 | 3,255 | -45 | -1.4% | 38,400 |
| 2023/07/03 | 3,320 | 3,330 | 3,295 | 3,300 | +10 | +0.3% | 18,600 |
| 2023/06/30 | 3,300 | 3,305 | 3,265 | 3,290 | -20 | -0.6% | 38,500 |
| 2023/06/29 | 3,335 | 3,350 | 3,280 | 3,310 | -15 | -0.5% | 25,100 |
| 2023/06/28 | 3,280 | 3,330 | 3,275 | 3,325 | +50 | +1.5% | 29,600 |
| 2023/06/27 | 3,270 | 3,280 | 3,240 | 3,275 | ±0 | ±0% | 18,600 |
| 2023/06/26 | 3,325 | 3,325 | 3,240 | 3,275 | -15 | -0.5% | 15,800 |
| 2023/06/23 | 3,300 | 3,315 | 3,280 | 3,290 | +5 | +0.2% | 29,900 |
| 2023/06/22 | 3,270 | 3,290 | 3,265 | 3,285 | +25 | +0.8% | 24,700 |
| 2023/06/21 | 3,260 | 3,295 | 3,250 | 3,260 | -5 | -0.2% | 43,600 |
| 2023/06/20 | 3,285 | 3,285 | 3,255 | 3,265 | -20 | -0.6% | 24,400 |
| 2023/06/19 | 3,325 | 3,335 | 3,265 | 3,285 | -40 | -1.2% | 34,400 |
| 2023/06/16 | 3,270 | 3,335 | 3,240 | 3,325 | +100 | +3.1% | 112,900 |
| 2023/06/15 | 3,265 | 3,275 | 3,225 | 3,225 | -35 | -1.1% | 53,000 |
| 2023/06/14 | 3,330 | 3,330 | 3,255 | 3,260 | -40 | -1.2% | 63,600 |
| 2023/06/13 | 3,330 | 3,345 | 3,295 | 3,300 | -55 | -1.6% | 47,600 |
| 2023/06/12 | 3,335 | 3,360 | 3,315 | 3,355 | +20 | +0.6% | 25,600 |
| 2023/06/09 | 3,305 | 3,355 | 3,305 | 3,335 | +30 | +0.9% | 44,000 |
| 2023/06/08 | 3,335 | 3,350 | 3,285 | 3,305 | -30 | -0.9% | 45,500 |
| 2023/06/07 | 3,365 | 3,405 | 3,335 | 3,335 | -5 | -0.1% | 54,500 |
| 2023/06/06 | 3,325 | 3,355 | 3,295 | 3,340 | -15 | -0.4% | 39,900 |
| 2023/06/05 | 3,420 | 3,435 | 3,335 | 3,355 | -5 | -0.1% | 40,600 |
| 2023/06/02 | 3,330 | 3,370 | 3,330 | 3,360 | +25 | +0.7% | 23,900 |
| 2023/06/01 | 3,345 | 3,395 | 3,325 | 3,335 | +45 | +1.4% | 42,400 |
| 2023/05/31 | 3,350 | 3,360 | 3,290 | 3,290 | -110 | -3.2% | 68,700 |
| 2023/05/30 | 3,435 | 3,455 | 3,380 | 3,400 | -55 | -1.6% | 21,400 |
| 2023/05/29 | 3,490 | 3,490 | 3,435 | 3,455 | +10 | +0.3% | 24,000 |
| 2023/05/26 | 3,540 | 3,540 | 3,420 | 3,445 | -75 | -2.1% | 45,700 |
| 2023/05/25 | 3,520 | 3,560 | 3,510 | 3,520 | -65 | -1.8% | 31,900 |
| 2023/05/24 | 3,600 | 3,625 | 3,580 | 3,585 | -35 | -1% | 21,100 |
| 2023/05/23 | 3,670 | 3,675 | 3,605 | 3,620 | -35 | -1% | 31,000 |
| 2023/05/22 | 3,585 | 3,655 | 3,585 | 3,655 | +25 | +0.7% | 23,900 |
| 2023/05/19 | 3,660 | 3,665 | 3,625 | 3,630 | -15 | -0.4% | 23,700 |
| 2023/05/18 | 3,690 | 3,695 | 3,615 | 3,645 | -55 | -1.5% | 31,900 |
| 2023/05/17 | 3,700 | 3,720 | 3,655 | 3,700 | -40 | -1.1% | 40,200 |
| 2023/05/16 | 3,660 | 3,745 | 3,660 | 3,740 | +150 | +4.2% | 51,600 |
| 2023/05/15 | 3,605 | 3,645 | 3,575 | 3,590 | -10 | -0.3% | 59,200 |
| 2023/05/12 | 3,565 | 3,610 | 3,540 | 3,600 | +50 | +1.4% | 37,000 |
| 2023/05/11 | 3,510 | 3,575 | 3,510 | 3,550 | +5 | +0.1% | 25,300 |
| 2023/05/10 | 3,580 | 3,585 | 3,540 | 3,545 | -30 | -0.8% | 22,200 |
451～
500
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
